Document is current
Any future updates will be listed below
-
Authors
Beech, Augusta S. https://orcid.org/0000-0002-2690-5364
Lea, Simon
Kolsum, Umme
Wang, Zhang
Miller, Bruce E.
Donaldson, Gavin C.
Wedzicha, Jadwiga A.
Brightling, Christopher E.
Singh, Dave
- License Information
-
More Information
Article History
Received: 2 July 2020
Accepted: 20 October 2020
First Online: 1 November 2020
Ethical approval and consent to participate
: All patients provided written informed consent using protocols approved by the local Ethics Committees at each site (Hampstead, 11/L0/1630; Greater Manchester South, 10/H/1003/108; East Midlands, 07/H0406/157).
: Not applicable.
: AB, SL, UK and ZW have no competing interests. BEM is a currently employee and shareholder of GSK. GD has received personal fees from Astra-Zeneca, American Thoracic Society, FWO, Belgium. JAW has received meeting expenses and grants from GSK, Johnson and Johnson, Novartis, Boehringer Ingelheim and Astra Zeneca. CEB has received grants or consultancy paid via his institution from MRC, GSK, AZ, Novartis, Pfizer AZ/MedImmune, Novartis, Chiesi, BI, 4DPharma, Mologic, Roche/Genentech, Sanofi and Regeneron. DS has received sponsorship to attend international meetings, honoraria for lecturing or attending advisory boards and research grants from various pharmaceutical companies including AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Genentech, GlaxoSmithKline, from Glenmark, Gossamerbio, Menarini, Mundipharma, Novartis, Peptinnovate, Pfizer, Pulmatrix, Theravance and Verona.
